Pro-Pharmaceuticals, Inc. Executives to Present Corporate Update at Three Investor Conferences in September

NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTC: PRWP), a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that Theodore Zucconi, Ph.D., Chief Executive Officer, James Czirr, Executive Chairman of the Board of Directors, and Peter Traber, M.D., Chief Medical Officer, Pro-Pharmaceuticals, Inc., are scheduled to present a corporate update at the Rodman and Renshaw Annual Global Investment Conference on Monday, September 13, 2010 at 4:30 pm EDT at The New York Palace Hotel in New York City. The presentation will be webcasted.